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From the start of early civilization, dog has
been man's best friend. In recent years man's
interest and ability in medical fields of technology
have greatly evolved. Along with this technology
canine lifespans have increased. Subsequently
diseases of older dogs such as cancer have
become more prominant. Pets are now thought of
as members of the family and because there are
more options available, owners are demanding
that their animals receive the best care possible.
Because of these developments, the 'field of
oncology is becoming vastly more important in
small animal medicine.
Few veterinary schools in the United States
have board certified oncologists. Here at Iowa
State University College of Veterinary Medicine,
wedo not have a board certified oncologist, but we
do have internal medicine clinicians and residents
who are genuinely interested in the field. One
such individual is Dr. Phil Ries, a resident in
internal medicine. Dr. Ries graduated with his
DVM from Ohio State University in 1988 and then
did an internship for 1 year in West Los Angeles
Veterinary Medicine Group. After completing his
internship, he practiced for an additional year in
southern California. He then came to Iowa State
to do a residency in internal medicine.
Dr. Ries' interest in oncology stems in part from
wanting to become competent in an area in which
he felt ignorant. It is also based on the fact that at
the Ohio State Teaching Hospital the referral case
load in oncology is quite large. In spite of the large
case load, Dr. Ries feels that most of what he has
learned about cancer in animals he has had to
learn from veterinary literature and more recently
his collegues at ISU Vet Teaching Hospital.
At this time at Iowa State, however, the case
load is moderate. This may be in part due to the
lack of a board certi'fied oncologist. Of the cases
that do come into the teaching hospital, Dr. Ries
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deals with manyofthem. The only majortreatment
that he is unable to provide to clients is radiation
therapy. These cases are referred schools which
are able to dispense such treatment.
Cancer comes in a wide variety of forms and
n1ay be treated in a number of ways. Surgery is a
method available to all practioners, provided the
procedure is not too involved. Another method of
treatment is radiation therapy in which special
equipment and appropriate licensing is required.
Chemotherapy is a forn1 of treatment that is most
often thought of when people think of cancer. As
in people, this may be used in animals.
Hyperthermia and immunotherapy are also being
used in the handling of various types of cancer.
These therapies do not have to be used alone. In
fact, they are often used in combination, i.e.,
surgery will often be followed by chemotherapy or
radiation therapy. As with surgery, private
practitioners should be able to provide
chemotherapy, but the cost of equipment for
radiation therapy makes it prohibitive.
At the Iowa State University Teaching Hospital
the most frequently diagnosed tun10r is
lymphosarcoma. This occurs in both dogs and
cats. Other frequently diagnosed tumors include
mammary tumors, mast cell tumors, and nasal
tumors.
In the case of lymphosarcoma, an owner will
generally bring in an animal because of sudden
anorexia and lethargy. They may also have
noticed lumps under the jaw or along the neck. In
many cases these lumps are found by the referring
veterinarian on a routine exam or when the animal
is brought in for another, unrelated problem. Often
by the time they are seen at the teaching hospital
by Dr. Ries, the disease is advanced, and the
tumor may have metastisized to multiple organs.
Dr. Ries related his typical chemotherapy
protocol for a lymphosarcoma case. He prefers to
use a combination therapy, although a single drug
therapy exists. He uses a cornbination of Cytoxan,
Vincristine and prednisone until the tumor is no
longer clinically apparent. Once the tumor is
clinically in remission he uses the same doses but
decreases the frequency of administration. In the
maintenance period, he replaces Cytoxan, an
alkylating agent, with Chlorarnbucil which is less
9
myelosuppressive. At home, the owneris expected
to give the animal Chlorambucil for four days
every other week and prednisone every other day.
The owner is also instructed to watch for signs that
may signal a relapse.
According to Dr. Ries, for the 70 to 80 percent
that go into remission, it can last for two weeks to
two years. In his experience, the average initial
remission lasts for about one year. Before an
animal is considered to be in remission, he/she
must be free of clinical signs of the tumor. This is
assessed by a thorough physical exam on every
visit. If a tumor relapses, Dr. Ries then generally
will try an alternative chemotherapy protocol. He
often uses is adriamycin, which is a broad spectrum
antibiotic antitumor. Generally the second
remission is shorter than thp. first
When an animal is put on chemotherapy drugs
it is very important to explain the possible side
effects to the owners. According to Dr. Ries,
clients tend to be well informed on the side effects
of chemotherapy drugs on humans, and they do
not want their pets to become more miserable
secondary to the treatment. Dogs and cats, as
compared to humans, have less severe side effects
to the drugs used. Most of the drugs work on
rapidly dividing cells, such as those found in the
bone marrow, GI tract, and those responsible for
hair growth. But unlike humans, hair loss, severe
nausea and GI upset, and bone marrow
suppression tend to be mild to moderate in most
cases.
Vincristine, for example, causes little or no
gastrointestinal upset. If an animal is experiencing
gastrointestinal problems a change in diet may
alleviate the symptoms. Generally, however, the
diet, as long as it is balanced, is not changed. The
tumor usually has little effect on the nutritional
status of the dog once it is in remission.
The cost of treatment, such as the one
mentioned above, varies with the size of the
animal. Dr. Ries quoted a price of about $750 for
a year of combination treatment. This
price was based on a forty pound dog with
lymphosarcoma. The price includes induction,
maintenance, check ups, and lab tests.
Dr. Ries feels that the future of the field of
oncology is huge and will only keep growing. New
therapies are being found and tried, some with
success. A real need exists for board certified
oncologists and oncology specialties at the referral
institutions.
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